miR-204-5p调节对PAX6调节和角膜炎症的影响
Mojdeh Abbasi1, Maryam Amini2, Petros Moustardas3
1Division of Ophthalmology, Department of Biomedical and Clinical Sciences, Linköping University, 581 83, Linköping, Sweden. mojdeh.abbasi@sydney.edu.au.
Scientific reports
|November 3, 2024
概括
通过调节PAX6.6,MicroRNA-204-5p显示出治疗先天性无血病的潜力. 虽然在实验室环境中是有效的,但它对与无菌相关的角质病变的体内疗效需要进一步研究.
科学领域:
- 眼科医生 眼科 眼科
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 先天性无视症是一种罕见的遗传性疾病,由于PAX6蛋白质缺乏,导致视力丧失.
- 安尼里迪亚相关的角膜病变是一种严重的并发症,影响角膜健康和视力敏度.
- 微RNA-204-5p正在作为PAX6功能的潜在调节剂进行研究.
研究的目的:
- 评估miR-204-5p对PAX6表达和相关因素在先天性无血病模型中的影响.
- 评估miR-204-5p的治疗潜力,在体外和体外模型中评估与无性相关的角质病变.
主要方法:
- 在人类四肢干细胞 (LSCs),永生角膜上皮细胞和初级角膜上皮细胞中,miR-204-5p的过度表达.
- 在体内研究中,使用LPS诱导的角质炎和Pax6缺乏的aniridia小鼠的小鼠模型.
- 对PAX6,ANGPT1和VEGFA的基因和蛋白质表达的分析.
- 评估炎症标志物和信号通路 (ERK1/2).
主要成果:
- 在体外,miR-204-5p抑制了ANGPT1并在特定情况下抑制了VEGFA,同时增加了PAX6的表达.
- 在患有LPS诱导的角膜炎的小鼠中,局部miR-204-5p减少了角膜炎症,但没有改变关键的分子标或拯救PAX6水平.
- 在aniridia小鼠模型中,miR-204-5p未能恢复PAX6水平,抑制VEGFA/ANGPT1或抑制ERK1/2通路.
结论:
- 短期miR-204-5p治疗在体外显示出可变的疗效,抑制血管因素和增强PAX6.
- 在体内治疗miR-204-5p对无菌性相关的角质病的疗效需要进一步的研究,特别是关于长期结果和疾病特异性模型中的疗效.
更多相关视频
04:43Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
Published on: June 16, 2023
876
04:48Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
236
相关概念视频
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...